Life Insurance
Consensus Index

AI Consensus Fit Review

John Hancock No-Exam or Accelerated Underwriting Indexed Universal Life Insurance Fit Review

John Hancock is a good — not guaranteed — fit for a healthy buyer seeking no-exam or accelerated underwriting indexed universal life (IUL) insurance.

Research: 2026-09-217 usable platform responsesRead the methodology ↗

Share

Answer Capsule

John Hancock is a good — not guaranteed — fit for a healthy buyer seeking no-exam or accelerated underwriting indexed universal life (IUL) insurance. Three of the seven platforms in this study named John Hancock during the ranking stage, and six of seven returned a usable fit assessment. The strongest reason to consider it is ExpressTrack, a reported exam- and lab-free accelerated underwriting pathway tied to Accumulation IUL and Protection IUL, backed by an A+ Superior AM Best rating for the U.S. issuing insurer. The main limitation is that no-exam treatment is never guaranteed: eligibility, face-amount limits, and current product rules conflict across public sources and must be verified before applying.

Research Snapshot

MetricValue
Platform mentions in ranking stage3 of 7 platforms
Share of included platform responses42.9%
Average listed rank2.67
Best listed rank2
Relevant product/model/planAccumulation IUL or Protection IUL, potentially submitted through John Hancock ExpressTrack accelerated underwriting
Overall use-case fitGood, with a verification condition
Research date2026-09-21

Why John Hancock Qualified for This Study

Questions This Section Answers

  • Why did John Hancock qualify for the best no-exam or accelerated underwriting indexed universal life insurance ranking?
  • Is John Hancock a good choice for a healthy buyer who wants IUL coverage without a paramedical exam?

John Hancock qualified because it combines a permanent indexed universal life product family with a publicly marketed accelerated underwriting program, which is the exact combination this study screened for. Three platforms — anthropic, deepseek, and google — named John Hancock during ranking discovery, with listed ranks of 2, 4, and 2 respectively (average 2.67, best 2). Six of the seven included platforms returned a usable fit assessment, and five of those six rated the fit "good" or "strong."

The qualification rests on three evidence pillars. First, product relevance: John Hancock's Accumulation IUL and Protection IUL are indexed universal life products with indexed interest-crediting potential and a 0% floor [1]. Second, an accelerated pathway: a third-party brokerage reference identifies John Hancock ExpressTrack as an accelerated-underwriting program and states there is no paramedical visit [2]. Third, financial strength: AM Best reports an A+ Superior Financial Strength Rating with a stable outlook for John Hancock life insurance Company (U.S.A.), effective December 12, 2025 [3].

Qualification is not the same as endorsement. The ranking-stage product label merges Accumulation IUL, Protection IUL, and accelerated underwriting, and the reviewed sources do not establish that every listed product is currently submitted through the same ExpressTrack rules. Buyers comparing carriers across this category can review the full No-Exam or Accelerated Underwriting Indexed Universal Life Insurance consensus index before narrowing to a single carrier.

The Product, Model, Plan, or Service Most Relevant to No-Exam or Accelerated Underwriting Indexed Universal Life Insurance

Questions This Section Answers

  • Which John Hancock product should a buyer choose for no-exam indexed universal life coverage — Accumulation IUL or Protection IUL?
  • Does John Hancock ExpressTrack apply to Accumulation IUL and Protection IUL for a healthy applicant?

The relevant offer is Accumulation IUL or Protection IUL, potentially submitted through John Hancock ExpressTrack accelerated underwriting. Platforms described the pairing slightly differently — anthropic and perplexity both referenced "Accumulation IUL and Protection IUL with ExpressTrack Underwriting," grok narrowed to "Accumulation IUL with ExpressTrack," and openai used "Accumulation IUL or Protection IUL, potentially submitted through John Hancock ExpressTrack" — but the product family is consistent across all six fit assessments.

Accumulation IUL is positioned around cash value accumulation and retirement income, with diverse indexed account options and a SimpleLock Capped Indexed Account intended to reduce exposure to market volatility [4]. Protection IUL is positioned more toward protection-oriented permanent coverage. Both are indexed universal life products with indexed interest-crediting potential and a 0% floor [7]. Accumulation IUL includes a no-lapse guarantee subject to stated conditions [8].

ExpressTrack is the accelerated underwriting mechanism. One platform reported it as exam- and lab-free, available to ages 18–60 for single-life coverage up to $5 million, with instant decision potential and issuance in as little as one day [9]. Another described automated data checks including prescription records, MIB, and third-party data sources, with qualifying applicants receiving decisions based on health data rather than a traditional exam [12]. A third reported ExpressTrack as available for single-life term and permanent applications including IUL with long-term care rider combinations, with no phone interview required for e-applications [14].

The unresolved question is whether Accumulation IUL and Protection IUL share identical ExpressTrack eligibility. One platform explicitly flagged that ranking-stage normalization mentions "Accumulation IUL with ExpressTrack Underwriting" specifically, while its independent source only confirmed "single-life term and permanent applications" including IUL generically [14]. Buyers should confirm product-level eligibility rather than assuming parity.

What the AI Platforms Agreed About

Questions This Section Answers

  • Do AI platforms agree that John Hancock is a good fit for no-exam or accelerated underwriting IUL?
  • What do reviewers agree John Hancock does well for accelerated underwriting indexed universal life insurance?

Agreement was strong but not unanimous. Five of the six platforms that returned a fit assessment rated John Hancock "good" or "strong"; one rated it "mixed." No platform rated it poor or unsuitable.

The clearest shared finding is that ExpressTrack is a real, marketed accelerated underwriting pathway tied to John Hancock's IUL products. Multiple platforms independently described it as exam- and lab-free for qualifying applicants, with electronic data review replacing the traditional paramedical exam [15]. One platform reported that qualifying applicants can receive a 100% instant underwriting decision using health data rather than a traditional exam [19].

Platforms also agreed on financial strength. AM Best reports an A+ Superior rating with stable outlook for the U.S. issuing insurer effective December 12, 2025 [20]. Independent review sources reported A+ from AM Best, AA- from S&P, A1 from Moody's, and AA from Fitch, with Manulife Financial Corporation as parent [21].

A third area of agreement is that the no-exam pathway is not a guarantee. Multiple platforms stated that underwriting review may still require a medical exam even for applicants who meet initial ExpressTrack criteria, and that exam requirements depend on age, health, and coverage amount [24]. One platform noted that if a case does not qualify for acceleration, John Hancock may move it to traditional underwriting rather than decline solely for missing ExpressTrack criteria [26].

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

  • What is the current John Hancock ExpressTrack maximum face amount — $3 million or $5 million?
  • Are John Hancock's IUL fees and cap rates competitive with other no-exam IUL carriers in 2026?

The largest documented conflict is the ExpressTrack maximum face amount. One John Hancock page for Protection IUL states that consumers 18–60 applying via JH eApp for single-life coverage up to $3 million are eligible for ExpressTrack [27]. Other sources and launch materials describe increased eligibility up to $5 million for certain single-life cases [28]. One platform noted that older sources list lower face-amount limits than recent expansions [32]. This conflict is unresolved in the supplied evidence and must be confirmed with John Hancock directly.

The second disagreement concerns competitive positioning on policy economics. One platform cited independent 2026 analysis stating that Mutual of Omaha, Securian Financial, and Nationwide have pulled ahead on fee structures, cap rates, and accumulation design, and that head-to-head illustrations show those carriers producing better outcomes [34]. No other platform in this study made a comparable competitive claim, so this finding is single-platform and should be treated as one reviewer's analysis rather than consensus.

Pricing transparency is a shared uncertainty. No platform located a reliable public consumer quote or fixed premium schedule. One platform reported a $20 monthly administrative charge, a 7% premium charge in years 1–10, a 2% premium charge after year 10, a 1.98% annual indexed performance charge on specified indexed-account balances, and a 12-year surrender-charge period for a referenced Accumulation IUL product version — while explicitly warning these figures may not apply to the current issue state, product version, or buyer's contract [36]. Another platform reported different figures: premium loads of 7% in year 1, 8% in years 2–10, and 2% thereafter, a $10 monthly administrative charge, and indexed performance charges of 0.96%–4.98% annualized on certain accounts [37]. These two sets of numbers conflict and neither is confirmed as current.

Additional uncertainties: whether ExpressTrack applies to Accumulation IUL in all states and age/face bands in 2026 is unclear [38]; the precise data sources, consent language, and circumstances requiring an exam remain unclear [39]; and one platform noted that Protection IUL '26 is not approved in Florida, Guam, and New York [30].

Use-Case-Specific Features and Capabilities

Questions This Section Answers

  • What features does John Hancock offer for a healthy buyer who wants no-exam indexed universal life insurance?
  • Does John Hancock's Vitality program reduce IUL premiums, and how much does it cost?

John Hancock's use-case fit rests on four capabilities: an accelerated underwriting pathway, electronic health data review, indexed crediting with downside protection, and a wellness program that can offset premium.

Accelerated underwriting. ExpressTrack is described as exam- and lab-free for qualifying applicants, with reduced cycle times and policies issued in as little as one day in some cases [40]. One platform reported decisions in as little as three days or instant via digital submission and health data review [42]. Another reported no phone interview required for term or permanent e-applications [44]. These turnaround figures are platform-reported and were not independently verified.

Electronic data review. ExpressTrack uses automated data checks including prescription records, MIB, and third-party data sources, with qualifying applicants receiving decisions based on health data rather than a traditional exam [45]. One platform described the process as using telephone interview, Rx/MVR/MIB/FCRA-type checks, with fallback to traditional underwriting if the client does not qualify [46]. Another noted a post-issue APS for quality assurance and that some impairments route to traditional underwriting [42].

Indexed crediting. IUL products offer interest crediting based on S&P 500 and Hang Seng index performance with downside protection [47]. Accumulation IUL includes a SimpleLock Capped Indexed Account intended to reduce exposure to market volatility [48]. The consumer guide describes indexed interest credits and a 0% floor [49].

Vitality wellness program. Vitality is available on both Protection IUL and Accumulation IUL, with policyholders earning rewards for healthy living [50]. Vitality GO is included automatically, or clients can choose Vitality PLUS for $2 per month, with opportunities for premium savings and rewards [51]. One platform stated premium savings of up to 25%, while noting actual savings depend on individual health activities and program engagement [51].

Riders. Available riders include Long-Term Care, Chronic Illness, Critical Illness Benefit, Accelerated Benefit (no-cost, up to 50% of death benefit to $1 million), Return of Premium, Cash Value Enhancement, and Estate Preservation [52]. Rider availability depends on the product, state of policy ownership, and other factors, and some carry additional fees [54].

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

  • How much does John Hancock Accumulation IUL cost per month, and what administrative and premium charges apply?
  • What surrender charges and no-lapse guarantee conditions should a buyer confirm before signing a John Hancock IUL contract?

No reliable public consumer quote or fixed premium schedule was located by any platform. IUL pricing is individualized by age, sex, health, underwriting class, face amount, riders, premium pattern, state, and policy design, and a personalized illustration and policy contract are required to evaluate actual cost [55]. Pricing confidence was rated low by four platforms and moderate by one.

The two fee disclosures that surfaced conflict. One platform reported a $20 monthly administrative charge, a 7% premium charge in years 1–10, a 2% premium charge after year 10, a 1.98% annual indexed performance charge on specified indexed-account balances, and a 12-year surrender-charge period for a referenced Accumulation IUL product version [55]. Another reported premium loads of 7% in year 1, 8% in years 2–10, and 2% thereafter, a $10 monthly administrative charge, cost-of-insurance based on the 2017 CSO table, and indexed performance charges of 0.96%–4.98% annualized on certain accounts [56]. Neither platform confirmed these figures apply to a 2026-issued policy in the buyer's state.

Contract mechanics that platforms flagged: surrender charges can reduce cash surrender value during the surrender-charge period; policy loans, withdrawals, insufficient premiums, or adverse credited performance can reduce cash value and may cause lapse if the policy is not adequately funded; and guarantees depend on the issuer's claims-paying ability and compliance with policy requirements [55]. Accumulation IUL includes a no-lapse guarantee that protects the policy from lapse if cash surrender value falls to zero or below, provided a cumulative premium test is met [57]. SEC-filed John Hancock variable universal life materials disclose ongoing policy charges, surrender charges, premium charges, administrative charges, cost-of-insurance charges, and loan-related costs, illustrating that exact contract economics are product-specific [58].

One platform stated that accelerated underwriting does not carry a premium surcharge versus medically underwritten policies for qualifying applicants, distinguishing it from simplified or guaranteed issue products [59]. Another noted that non-medical IUL typically costs 10–30% more than fully underwritten coverage in general industry terms, though that figure is not John Hancock-specific [60].

Best Suited For

Questions This Section Answers

  • Who is John Hancock best suited for among buyers seeking no-exam indexed universal life insurance?
  • Is John Hancock a good fit for a health-conscious buyer who wants permanent IUL coverage up to $5 million?

John Hancock is best suited to healthy applicants who prioritize permanent indexed life insurance and are willing to complete detailed health questions and authorize electronic data, prescription, and medical-record reviews [61]. The strongest fit is a buyer who values accelerated underwriting speed and wellness integration over absolute lowest fees.

Specific profiles that platforms identified as well matched:

  • Applicants aged 18–60 seeking accelerated or no-exam underwriting pathways with coverage up to $5 million [62].
  • Health-conscious consumers who want to leverage Vitality wellness rewards, with reported premium savings up to 25% [65].
  • Buyers who prioritize underwriting flexibility and fast issuance over maximum accumulation design [67].
  • Applicants in good health willing to provide electronic medical records, prescription history, and consumer data [69].
  • Those seeking permanent IUL coverage with long-term care rider availability [71].
  • Applicants seeking accumulation-oriented IUL features, including indexed crediting, a 0% indexed-account floor, and a built-in no-lapse guarantee subject to stated conditions [72].

One platform rated the fit "strong" for healthy U.S. consumers aged 18–60 seeking up to $5 million in Accumulation IUL via ExpressTrack [74]. Another rated it "mixed," citing age limits, rate-class floors, and undocumented IUL economics [64]. The spread between those ratings is itself useful information: fit depends heavily on whether the buyer's profile matches ExpressTrack parameters.

Probably Not Best Suited For

Questions This Section Answers

  • Who should not choose John Hancock for no-exam or accelerated underwriting indexed universal life insurance?
  • Is John Hancock a poor fit for applicants over 60 or buyers who need coverage above $5 million without an exam?

John Hancock is probably not the best fit for buyers who need certainty rather than a pathway. Platforms identified several profiles where another option is likely better.

Applicants who require a guaranteed no-exam approval regardless of age, health history, coverage amount, or prescription profile should look elsewhere [75]. ExpressTrack is not guaranteed issue; applicants must still answer health questions and undergo data review [76]. Multiple sources state the exam is not required for ExpressTrack but also note an exam may still be required depending on underwriting review, with no clarity on what percentage of ExpressTrack applicants avoid exams in practice [77].

Applicants over age 60 fall outside ExpressTrack's reported age band [79]. One platform listed the age restriction as a limitation that shuts out older buyers seeking no-exam IUL [80].

Buyers needing coverage above $5 million through accelerated underwriting would exceed the reported ExpressTrack ceiling and require traditional underwriting [81].

Buyers seeking simple, low-cost protection should consider term insurance or guaranteed-issue products instead [75]. Buyers primarily seeking investment accumulation with transparent, low ongoing costs rather than insurance protection are also a weaker match [75].

Buyers who cannot or will not provide electronic health data or medical authorization are not suited to this pathway [82]. Buyers who do not value or will not use the Vitality wellness program lose one of the carrier's differentiating features [84].

Buyers who want self-service digital purchasing without advisor interaction should note that John Hancock policies are available through licensed financial advisors and appointed independent agents rather than direct online purchase [85].

When Another Option May Be Better

Questions This Section Answers

  • What is a better alternative to John Hancock for a buyer who needs coverage above $5 million without a medical exam?
  • Which carrier should a buyer compare against John Hancock if maximum cash value accumulation is the priority?

Another option may be better in five specific situations that platforms identified.

When maximum cash value accumulation is the priority. One platform cited independent 2026 analysis stating that Mutual of Omaha, Securian Financial, and Nationwide have pulled ahead on fee structures, cap rates, and accumulation design, with head-to-head illustrations showing those carriers producing better outcomes [86]. This is a single-platform finding and should be tested with side-by-side illustrations rather than accepted as settled.

When coverage above $5 million is needed without exam risk. One platform noted that Penn Mutual offers up to $10 million accelerated underwriting for term, whole, and universal life including IUL [88].

When the buyer is over age 60. One platform suggested United Life LegacyAccel IUL, which it reported as available for ages 18–85 with no medical testing required unless net amount at risk exceeds $400,000 (ages 18–75) or $200,000 (ages 76–85), and death benefits from $25,000 to $9.999 million [89].

When published fee transparency matters. One platform noted that Lincoln WealthAccelerate IUL publishes detailed premium loads and charges, including premium loads of 12% in years 1–5 below a threshold and 20% in years 1–20 above it, a $6 monthly policy fee, and surrender charges for nine years [90].

When the buyer is rated or substandard. Simplified issue or guaranteed issue products, or carriers with more lenient accelerated thresholds, may be more appropriate [91].

Buyers who want to compare John Hancock against the broader field can browse the life insurance category directory before requesting illustrations.

Questions to Verify Before Buying

Questions This Section Answers

  • What should a buyer confirm with John Hancock before signing an indexed universal life contract?
  • How can a buyer verify ExpressTrack eligibility and current IUL charges before applying?

Platforms converged on a verification checklist. The recurring items:

  1. Is the current application for Accumulation IUL or Protection IUL eligible for ExpressTrack in the buyer's state [92]?
  2. What is the current ExpressTrack maximum face amount — $3 million or $5 million — and does the higher limit apply to the specific IUL product with full feature parity [93]?
  3. What are the current ExpressTrack issue-age, face-amount, health-history, build, prescription, and tobacco limits [92]?
  4. Will a paramedical exam, lab work, APS, or additional records be required if electronic data is incomplete or unfavorable [92]?
  5. What percentage of applicants in the buyer's profile are routed to full underwriting, and what is the expected decision timeline [92]?
  6. Which legal John Hancock insurer will issue the policy, and what are its current financial-strength ratings [92]?
  7. What are the guaranteed and current premium loads, administrative charges, cost-of-insurance rates, indexed-account charges, surrender charges, loan rates, and rider charges for the proposed policy [92]?
  8. What caps, participation rates, spreads, and indexed-account charges apply today, and can those parameters change [92]?
  9. What premium is required to maintain the no-lapse guarantee, and what happens after the guarantee period ends [92]?
  10. How do planned loans, withdrawals, premium skips, or reduced premiums affect lapse risk and death benefits [92]?
  11. Can the agent provide guaranteed and current-value illustrations using conservative assumptions and a side-by-side comparison with at least two competing accelerated-underwriting IUL carriers [92]?
  12. What are the Vitality program mechanics — which health activities and data are tracked, and what is the expected annual premium reduction for the buyer's profile [97]?
  13. Is Protection IUL and Accumulation IUL available in the buyer's state, especially in Florida, Guam, or New York [98]?
  14. What are the long-term care rider costs, benefit triggers, and how do benefits interact with the IUL death benefit [99]?

Final AI Consensus Verdict

John Hancock is a good fit for a healthy buyer seeking no-exam or accelerated underwriting indexed universal life insurance, with an important verification condition. Five of six platforms that returned a fit assessment rated it good or strong; one rated it mixed. The strongest reason to consider it is ExpressTrack, a reported exam- and lab-free accelerated underwriting pathway tied to Accumulation IUL and Protection IUL, combined with an A+ Superior AM Best rating for the U.S. issuing insurer as of December 12, 2025 [101].

The main limitation is that no-exam treatment is never guaranteed. ExpressTrack is not guaranteed issue; applicants must still answer health questions and undergo data review, and an exam may still be required depending on the individual profile [102]. Public sources also conflict on the maximum face amount — $3 million versus $5 million — and no platform located a reliable public premium quote.

John Hancock should not be treated as the strongest option until the agent verifies that the exact current IUL product, state, face amount, and health profile qualify for ExpressTrack and provides the complete guaranteed and current illustration [105]. Buyers whose primary goal is maximum cash value accumulation should compare against Mutual of Omaha, Securian, or Nationwide before committing [106]. Buyers who prioritize accelerated underwriting speed and wellness integration over absolute lowest fees will find John Hancock a reasonable candidate.

How This Review Was Produced

This review synthesizes fit assessments from seven AI platforms asked to recommend life insurance carriers for a healthy consumer seeking indexed universal life coverage with a possible no-paramedical-exam underwriting process. Three platforms named John Hancock during ranking discovery; six returned a usable fit assessment. Platform research dates were 2026-09-21 for anthropic, grok, kimi, openai, and perplexity, and 2026-01-15 for deepseek. The authoritative study date is 2026-09-21.

Platforms used different models and search configurations: anthropic (claude-haiku-4-5-20251001, native search), deepseek (deepseek-v4-flash, no search enabled), google (gemini-3.5-flash, native search), grok (x-ai/grok-4.3, server tool search), kimi (moonshotai/kimi-k2.6, web plugin search), openai (gpt-5.6-luna, native search), and perplexity (perplexity/sonar, native options search). All platform outputs carry a verification status of platform-reported, not independently verified.

Methodology Limitations

Several limitations affect how much weight this review can carry.

Not unanimous. Six of seven included platforms returned a usable fit assessment. Fit findings should not be described as unanimous. Platform mention counts reflect only platforms that named John Hancock during ranking discovery.

Platform-reported evidence. Citations are platform-reported evidence, not independently verified facts. Claims from platforms without search enabled require explicit verification before being described as current facts. Deepseek's assessment was produced without search enabled and its research date (2026-01-15) differs from the authoritative run date.

Conflicting product and pricing details. Public sources conflict on the ExpressTrack maximum face amount ($3 million versus $5 million), on administrative charges ($10 versus $20 monthly), and on premium load schedules. These conflicts were not resolved by guessing; buyers should verify current parameters directly.

Official-site retrieval failed. The John Hancock official website returned an HTTP 403 during retrieval and no official-page excerpts were captured. Product details in this review rely on financial-professional, producer, and independent review sources rather than the carrier's own consumer pages.

Unvalidated URLs. The supplied source URLs were collected from platform responses and were not independently validated by the writer stage.

Missing pricing. No platform located a reliable public consumer quote or fixed premium schedule for John Hancock IUL. Pricing confidence was rated low by four platforms and moderate by one.

Identity qualification notes. Official-site retrieval failed for one or more mentions; no failed fetch was used as a verified domain key. Identity used exact-name fallback, and company-name variants were collapsed onto one canonical brand before minimum-mentions qualification.

No independent verification. This review does not include personal testing, customer experience data, or independent verification of carrier claims. AI-platform agreement does not prove product quality.

Sources

Company-Owned Sources

  • John Hancock Accumulation IUL Producer Guide: https://www.jhillust.com/JH_Help/JHIllustrator/SupportDocs/AIUL.pdf
  • John Hancock official website: insurance products and underwriting information: https://www.johnhancock.com/
  • Additional AI research evidence107 records
    1. AI research evidence record openai:c1
    2. AI research evidence record openai:c3
    3. AI research evidence record openai:c4
    4. AI research evidence record anthropic:c7
    5. AI research evidence record anthropic:c8
    6. AI research evidence record anthropic:c10
    7. AI research evidence record openai:c1
    8. AI research evidence record openai:c2
    9. AI research evidence record anthropic:c1
    10. AI research evidence record anthropic:c2
    11. AI research evidence record anthropic:c3
    12. AI research evidence record anthropic:c4
    13. AI research evidence record anthropic:c5
    14. AI research evidence record kimi:terminsurancebrokers-express
    15. AI research evidence record anthropic:c1
    16. AI research evidence record anthropic:c3
    17. AI research evidence record perplexity:c1
    18. AI research evidence record kimi:terminsurancebrokers-express
    19. AI research evidence record anthropic:c5
    20. AI research evidence record openai:c4
    21. AI research evidence record anthropic:c11
    22. AI research evidence record anthropic:c12
    23. AI research evidence record grok:4
    24. AI research evidence record anthropic:c17
    25. AI research evidence record anthropic:c18
    26. AI research evidence record perplexity:c8
    27. AI research evidence record perplexity:c3
    28. AI research evidence record perplexity:c2
    29. AI research evidence record anthropic:c1
    30. AI research evidence record anthropic:c2
    31. AI research evidence record kimi:terminsurancebrokers-express
    32. AI research evidence record grok:0
    33. AI research evidence record grok:7
    34. AI research evidence record anthropic:c15
    35. AI research evidence record anthropic:c16
    36. AI research evidence record openai:c2
    37. AI research evidence record grok:1
    38. AI research evidence record deepseek:jh1
    39. AI research evidence record openai:c3
    40. AI research evidence record anthropic:c1
    41. AI research evidence record anthropic:c3
    42. AI research evidence record grok:0
    43. AI research evidence record grok:7
    44. AI research evidence record kimi:terminsurancebrokers-express
    45. AI research evidence record anthropic:c4
    46. AI research evidence record perplexity:c5
    47. AI research evidence record anthropic:c9
    48. AI research evidence record anthropic:c10
    49. AI research evidence record openai:c1
    50. AI research evidence record anthropic:c13
    51. AI research evidence record anthropic:c14
    52. AI research evidence record anthropic:c23
    53. AI research evidence record anthropic:c25
    54. AI research evidence record anthropic:c24
    55. AI research evidence record openai:c2
    56. AI research evidence record grok:1
    57. AI research evidence record anthropic:c2
    58. AI research evidence record openai:c5
    59. AI research evidence record kimi:wsj-no-exam
    60. AI research evidence record kimi:starwest-iul-guide
    61. AI research evidence record openai:c3
    62. AI research evidence record anthropic:c1
    63. AI research evidence record anthropic:c2
    64. AI research evidence record kimi:terminsurancebrokers-express
    65. AI research evidence record anthropic:c13
    66. AI research evidence record anthropic:c14
    67. AI research evidence record anthropic:c26
    68. AI research evidence record anthropic:c27
    69. AI research evidence record anthropic:c4
    70. AI research evidence record anthropic:c5
    71. AI research evidence record anthropic:c23
    72. AI research evidence record openai:c1
    73. AI research evidence record openai:c2
    74. AI research evidence record grok:0
    75. AI research evidence record openai:c3
    76. AI research evidence record perplexity:c3
    77. AI research evidence record anthropic:c17
    78. AI research evidence record anthropic:c18
    79. AI research evidence record anthropic:c1
    80. AI research evidence record kimi:terminsurancebrokers-express
    81. AI research evidence record anthropic:c20
    82. AI research evidence record anthropic:c4
    83. AI research evidence record anthropic:c5
    84. AI research evidence record anthropic:c14
    85. AI research evidence record anthropic:c19
    86. AI research evidence record anthropic:c15
    87. AI research evidence record anthropic:c16
    88. AI research evidence record kimi:investopedia-no-exam
    89. AI research evidence record kimi:unitedlife-legacyaccel
    90. AI research evidence record kimi:lincoln-wealthaccelerate
    91. AI research evidence record kimi:terminsurancebrokers-express
    92. AI research evidence record openai:c3
    93. AI research evidence record perplexity:c3
    94. AI research evidence record anthropic:c1
    95. AI research evidence record kimi:terminsurancebrokers-express
    96. AI research evidence record anthropic:c17
    97. AI research evidence record anthropic:c14
    98. AI research evidence record anthropic:c2
    99. AI research evidence record anthropic:c23
    100. AI research evidence record anthropic:c24
    101. AI research evidence record openai:c4
    102. AI research evidence record perplexity:c3
    103. AI research evidence record anthropic:c17
    104. AI research evidence record anthropic:c18
    105. AI research evidence record openai:c3
    106. AI research evidence record anthropic:c15
    107. AI research evidence record anthropic:c16

Independent Sources

Other Sources

  • PDF Accelerated Underwriting (Labs Free/Fluidless) Producer Information: https://www.agencyone.net/wp-content/uploads/2020/04/PRODUCER-AUP-CURRENT-Spreadsheet-with-Tabs.pdf
  • Accumulation IUL policy fees and charges support document: https://www.jhillust.com/JH_Help/JHIllustrator/SupportDocs/AIUL18.pdf
  • Accumulation Variable Universal Life 2025 Summary Prospectus: https://www.sec.gov/Archives/edgar/data/801019/000119312525088781/d933554d497vpi.htm
  • Additional AI research evidence107 records
    1. AI research evidence record openai:c1
    2. AI research evidence record openai:c3
    3. AI research evidence record openai:c4
    4. AI research evidence record anthropic:c7
    5. AI research evidence record anthropic:c8
    6. AI research evidence record anthropic:c10
    7. AI research evidence record openai:c1
    8. AI research evidence record openai:c2
    9. AI research evidence record anthropic:c1
    10. AI research evidence record anthropic:c2
    11. AI research evidence record anthropic:c3
    12. AI research evidence record anthropic:c4
    13. AI research evidence record anthropic:c5
    14. AI research evidence record kimi:terminsurancebrokers-express
    15. AI research evidence record anthropic:c1
    16. AI research evidence record anthropic:c3
    17. AI research evidence record perplexity:c1
    18. AI research evidence record kimi:terminsurancebrokers-express
    19. AI research evidence record anthropic:c5
    20. AI research evidence record openai:c4
    21. AI research evidence record anthropic:c11
    22. AI research evidence record anthropic:c12
    23. AI research evidence record grok:4
    24. AI research evidence record anthropic:c17
    25. AI research evidence record anthropic:c18
    26. AI research evidence record perplexity:c8
    27. AI research evidence record perplexity:c3
    28. AI research evidence record perplexity:c2
    29. AI research evidence record anthropic:c1
    30. AI research evidence record anthropic:c2
    31. AI research evidence record kimi:terminsurancebrokers-express
    32. AI research evidence record grok:0
    33. AI research evidence record grok:7
    34. AI research evidence record anthropic:c15
    35. AI research evidence record anthropic:c16
    36. AI research evidence record openai:c2
    37. AI research evidence record grok:1
    38. AI research evidence record deepseek:jh1
    39. AI research evidence record openai:c3
    40. AI research evidence record anthropic:c1
    41. AI research evidence record anthropic:c3
    42. AI research evidence record grok:0
    43. AI research evidence record grok:7
    44. AI research evidence record kimi:terminsurancebrokers-express
    45. AI research evidence record anthropic:c4
    46. AI research evidence record perplexity:c5
    47. AI research evidence record anthropic:c9
    48. AI research evidence record anthropic:c10
    49. AI research evidence record openai:c1
    50. AI research evidence record anthropic:c13
    51. AI research evidence record anthropic:c14
    52. AI research evidence record anthropic:c23
    53. AI research evidence record anthropic:c25
    54. AI research evidence record anthropic:c24
    55. AI research evidence record openai:c2
    56. AI research evidence record grok:1
    57. AI research evidence record anthropic:c2
    58. AI research evidence record openai:c5
    59. AI research evidence record kimi:wsj-no-exam
    60. AI research evidence record kimi:starwest-iul-guide
    61. AI research evidence record openai:c3
    62. AI research evidence record anthropic:c1
    63. AI research evidence record anthropic:c2
    64. AI research evidence record kimi:terminsurancebrokers-express
    65. AI research evidence record anthropic:c13
    66. AI research evidence record anthropic:c14
    67. AI research evidence record anthropic:c26
    68. AI research evidence record anthropic:c27
    69. AI research evidence record anthropic:c4
    70. AI research evidence record anthropic:c5
    71. AI research evidence record anthropic:c23
    72. AI research evidence record openai:c1
    73. AI research evidence record openai:c2
    74. AI research evidence record grok:0
    75. AI research evidence record openai:c3
    76. AI research evidence record perplexity:c3
    77. AI research evidence record anthropic:c17
    78. AI research evidence record anthropic:c18
    79. AI research evidence record anthropic:c1
    80. AI research evidence record kimi:terminsurancebrokers-express
    81. AI research evidence record anthropic:c20
    82. AI research evidence record anthropic:c4
    83. AI research evidence record anthropic:c5
    84. AI research evidence record anthropic:c14
    85. AI research evidence record anthropic:c19
    86. AI research evidence record anthropic:c15
    87. AI research evidence record anthropic:c16
    88. AI research evidence record kimi:investopedia-no-exam
    89. AI research evidence record kimi:unitedlife-legacyaccel
    90. AI research evidence record kimi:lincoln-wealthaccelerate
    91. AI research evidence record kimi:terminsurancebrokers-express
    92. AI research evidence record openai:c3
    93. AI research evidence record perplexity:c3
    94. AI research evidence record anthropic:c1
    95. AI research evidence record kimi:terminsurancebrokers-express
    96. AI research evidence record anthropic:c17
    97. AI research evidence record anthropic:c14
    98. AI research evidence record anthropic:c2
    99. AI research evidence record anthropic:c23
    100. AI research evidence record anthropic:c24
    101. AI research evidence record openai:c4
    102. AI research evidence record perplexity:c3
    103. AI research evidence record anthropic:c17
    104. AI research evidence record anthropic:c18
    105. AI research evidence record openai:c3
    106. AI research evidence record anthropic:c15
    107. AI research evidence record anthropic:c16

Verify this research

Check when the research was run, which platforms were included, and what supports the findings.

Study date
September 21, 2026
Platforms analyzed
7
Source records
38
Ranking mentions
3 of 7
Platform share
43%
Final consensus rank
#3

Behind the findings

Platforms in this study

  • ChatGPT
  • Claude
  • DeepSeek
  • Grok
  • Perplexity
  • Kimi
  • Gemini

Source records

18 independent · 10 company-owned · 10 unclear

Evidence support

26 direct · 12 partial

Keep in mind

Use the run research_date as the study date. Platform-reported dates are provenance metadata and do not independently prove freshness.

Technical verification details

Use this SHA-256 fingerprint to identify the source snapshot associated with this study.

8eeefa167409825be922b5b382b4326417bafa42343a9a5a5a07b718d9381254